Dual phosphodiesterase type 5 inhibitor therapy for refractory pulmonary arterial hypertension: A pilot study

Mai Kimura, Yuichi Tamura, Makoto Takei, Tsunehisa Yamamoto, Tomohiko Ono, Jun Fujita, Masaharu Kataoka, Masataka Kuwana, Toru Satoh, Keiichi Fukuda

Research output: Contribution to journalArticlepeer-review

4 Citations (Scopus)

Fingerprint Dive into the research topics of 'Dual phosphodiesterase type 5 inhibitor therapy for refractory pulmonary arterial hypertension: A pilot study'. Together they form a unique fingerprint.

Medicine & Life Sciences